The
Intellectual Property Owners Association (IPO) will offer a one-hour webinar
entitled: "The Gene Uncertainty: What to Do After Myriad" on Tuesday,
May 25, 2010 beginning at 2:00 PM (EST). 
The IPO webinar will present a panel of experts in biotech patent
prosecution and litigation that will examine options for companies having gene
patents or planning to file for gene patents after the decision Association for Molecular Pathology v. U.S.
Patent and Trademark Office. 
The speakers include Patent Docs
author Kevin Noonan of McDonnell Boehnen Hulbert & Berghoff LLP; Ken
Chahine of the S.J. Quinny College of Law at the University of Utah and the
BioLaw Project; and Ned A. Israelsen of Knobbe Martens Olson & Bear,
LLP.  The registration fee for the
webinar is $100.  Those interested
in registering for the webinar, can do so here.